Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-1900Fax+1 404-778-3002- Is this information wrong?
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013- Emory University School of MedicineResidency, Internal Medicine, 2007 - 2010
University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
GA State Medical License 2013 - 2025
Clinical Trials
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
- Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung Start of enrollment: 2016 Apr 10
- Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer Start of enrollment: 2017 Jul 21
Publications & Presentations
PubMed
- 6 citationsEfficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).Saad A. Khan, Z. Sun, Suzanne E. Dahlberg, Jyoti Malhotra, Roger Keresztes, Chukwuemeka Ikpeazu, Patrick Ma, Suresh S. Ramalingam, Rathi N. Pillai> ;JTO Clinical and Research Reports. 2021 May 1
- 8 citationsDaratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)Rathi N. Pillai, Suresh S. Ramalingam, Meena Thayu, Patricia Lorenzini, Diana A. Alvarez Arias, Christopher Moy, Natalie Hutnick, Roland Elmar Knoblauch, Huaibao Feng,...> ;JTO Clinical and Research Reports. 2021 Feb 1
- Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.Mehmet Asim Bilen, Dylan J Martini, Yuan Liu, Julie M Shabto, Jacqueline T Brown, Milton Williams, Amir I Khan, Alexandra Speak, Colleen Lewis, Hannah Collins, Haydn T...> ;The Oncologist. 2020 Mar 1
- Join now to see all
Journal Articles
- Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative AnalysisRathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck
- Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with RadiotherapyGabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer
Press Mentions
OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerJune 25th, 2019
T Cell Revival Correlates with Lung Cancer Response to PD-1 ImmunotherapyApril 24th, 2017
Cancer Immunotherapy: Revived T Cells Still Need FuelMarch 9th, 2017
Hospital Affiliations
Grady Health SystemAtlanta, Georgia
Emory University HospitalAtlanta, Georgia
Southern Regional Medical CenterRiverdale, Georgia
Emory University Hospital MidtownAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
